FDA Inspection 555314 — Carter BloodCare at Lockheed
The FDA completed an inspection of Carter BloodCare at Lockheed on January 7, 2009 in White Settlement, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 7, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- White Settlement, TX (United States)